Memantine vs Selank-Amidate

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Memantine and Selank-Amidate are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares Memantine and Selank-Amidate across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

MemantineSelank-Amidate
CategoryCognitive EnhancementCognitive Enhancement
Regulatory status (US)Research use onlyResearch use only
Typical dosage5-20 mg250-500 mcg
Frequencydailydaily
Reported benefitsNeuroprotection, memory support, cognitive preservationLonger-lasting anxiety relief, stable mood
Reported side effectsDizziness, headache possibleVery well-tolerated

Key differences

Primary use. Memantine is categorised under Cognitive Enhancement, while Selank-Amidate falls under Cognitive Enhancement. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. Memantine: not FDA-approved; treated as a research compound. Selank-Amidate: not FDA-approved; treated as a research compound.

Dosing. Memantine is typically dosed at 5-20 mg (daily). Selank-Amidate is typically dosed at 250-500 mcg (daily).

Can you stack them?

Some protocols combine peptides, but stacking Memantine and Selank-Amidate has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Memantine and Selank-Amidate?
Memantine and Selank-Amidate are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status. Memantine is not FDA-approved; generally classified as a research compound, whereas Selank-Amidate is not FDA-approved; generally classified as a research compound.
What is Memantine used for?
NMDA antagonist.
What is Selank-Amidate used for?
Extended release Selank.
Can you take Memantine and Selank-Amidate together?
Some users combine peptides within a single protocol, but stacking Memantine and Selank-Amidate has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Memantine or Selank-Amidate FDA-approved?
Memantine is not FDA-approved; generally classified as a research compound. Selank-Amidate is not FDA-approved; generally classified as a research compound.

Read the full articles

  • Memantine — full monograph: mechanism, research, dosing & references
  • Selank-Amidate — full monograph: mechanism, research, dosing & references

More Cognitive Enhancement comparisons

← All peptide comparisons